Remove 2020 Remove Clinic Remove Radiation
article thumbnail

Widespread Staff Shortages Exacerbate Pressures Facing Radiation Oncology Clinics; ASTRO Advocacy Day Calls for Action

Imaging Technology

milla1cf Tue, 05/23/2023 - 11:36 May 23, 2023 — More than 9 in 10 radiation oncologists report that their practices face clinical staff shortages , according to a new national survey from the American Society for Radiation Oncology ( ASTRO ). Radiation oncologists from across the country are in Washington, D.C.

article thumbnail

Dr. Vivek S. Kavadi Named CEO of the American Society for Radiation Oncology (ASTRO)

Imaging Technology

milla1cf Fri, 06/21/2024 - 20:25 June 21, 2024 — The American Society for Radiation Oncology ( ASTRO ) announced today that following a nationwide search, Vivek S. From 2003 to 2020, Dr. Kavadi served as Regional Medical Director for Texas Oncology, where he managed a 60-physician practice in the Houston region.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Blue Earth Therapeutics Announces Results of Early Clinical and Preclinical Studies of Investigational 177Lu-rhPSMA-10.1 in Treatment of Prostate Cancer

Imaging Technology

milla1cf Thu, 06/29/2023 - 21:10 June 29, 2023 — Blue Earth Therapeutics , a Bracco company and emerging leader in the development of innovative next generation therapeutic radiopharmaceuticals, today announced highlights from early clinical and preclinical studies of 177Lu-rhPSMA-10.1 higher tumor absorbed radiation dose.

Clinic 98
article thumbnail

Multi-Institutional Study Data Presented at ASTRO 2023 Builds Upon Growing Evidence of GammaTile for Patients with Brain Tumors

Imaging Technology

2 poster presentation at the American Society for Radiation Oncology's (ASTRO) 65th Annual Meeting, ASTRO 2023 , being held this week in San Diego, CA. sites were treated with GammaTile, a treatment that provides immediate radiation where it is needed most after brain tumor removal surgery.

article thumbnail

Blue Earth Diagnostics Announces Addition of POSLUMA (Flotufolastat F 18) Injection to NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer

Imaging Technology

We believe it further validates the clinical utility of POSLUMA in patients with newly diagnosed or recurrent prostate cancer, and can help expand patient access. FDA, as well as on the Phase 3 clinical trial results published recently in the Journal of Urology and European Urology. Chief Executive Officer of the Company. “We

article thumbnail

PSMA-PET helps plan treatment in men with relapsed prostate cancer

AuntMinnie

In data from a phase III clinical trial, the investigators found that gallium-68 (Ga-68) PSMA-11 PET initiated major management changes to salvage radiotherapy (RT) planning in 33% of patients – notably, a group for whom the technique was first approved in the U.S.

Radiation 111
article thumbnail

US Oncology Network chief to become ASTRO CEO

AuntMinnie

The American Society for Radiation Oncology (ASTRO) has appointed Texas radiation oncologist Vivek Kavadi, MD, as its new CEO. Kavadi plans to leave his current role as chief radiation oncology officer for the US Oncology Network to lead ASTRO, where he has been a member and served in various roles since 1994.